Co-targeting the IGF system and HIF-1 inhibits migration and invasion by (triple-negative) breast cancer cells

BACKGROUND: Metastatic triple-negative breast cancer is mostly incurable, due to lack of suitable drug targets. The insulin-like growth factor (IGF) system could provide such a target, and IGF-1 receptor (IGF-1R)-directed agents are already available, but seem unable to control all the complexities...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Mancini, M, Gariboldi, M B, Taiana, E, Bonzi, M C, Craparotta, I, Pagin, M, Monti, E
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2014
Gaiak:
Translational Therapeutics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4056066/
https://ncbi.nlm.nih.gov/pubmed/24853185
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.269
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak